CJC-1295 is a synthetic peptide that tells the pituitary gland to release more growth hormone. It has become popular in anti-aging, peptide therapy, and bodybuilding circles, but many online claims go far beyond what the human research actually shows. This review explains the published human studies I could locate, the halted Phase 2 HIV trial, the FDA safety concerns, and what CJC-1295 has and has not been proven to do.
Joe Cannon, MS, has spent more than 30 years researching supplements, nutrition science, and — more recently — peptide therapies, holding a B.S. in Chemistry and Biology and an M.S. in Exercise Science. Every article on this site is built from peer-reviewed clinical research first, with zero input from companies.
Quick Answer: Does CJC-1295 Really Work?
CJC-1295 has been shown to raise growth hormone and IGF-1 in small human studies. That part is real. But human trials have not proven that CJC-1295 builds muscle, burns fat, improves sleep, speeds recovery, or slows aging. It is also not FDA-approved, and the FDA has raised safety concerns about compounded CJC peptide products.
What Is CJC 1295 and How Does It Work?
CJC 1295 is a synthetic version of growth hormone-releasing hormone (GHRH). It was originally developed as a pharmaceutical drug candidate by the Canadian biotech company ConjuChem.
Here is the chain of events this peptide sets off:
- Your hypothalamus (a region of the brain) normally releases a hormone called growth hormone-releasing hormone (GHRH), which tells the pituitary gland to release GH.
- CJC-1295 is a synthetic version of GHRH, engineered to remain in the bloodstream longer than natural GHRH.
- More time in circulation means more sustained stimulation of the pituitary, which means a longer window of elevated GH.
- Elevated GH, in turn, raises IGF-1 (insulin-like growth factor 1), a hormone made mostly in the liver that's responsible for many of GH's downstream effects on muscle and fat tissue.
Translation
The CJC peptide tells the body to release more of its own growth hormone. It does not replace growth hormone directly.
What Is the Difference Between CJC 1295 With DAC and Without DAC?
This trips up a lot of people, so it's worth untangling. “DAC” stands for drug affinity complex, a chemical add-on that lets the CJC peptide bind to albumin, a protein that circulates in your blood. That binding is what gives CJC-1295 its long staying power.
| Version | Half-life | GH release pattern |
| CJC-1295 with DAC | About 6-8 days | Sustained, elevated above baseline |
| CJC-1295 without DAC (Mod GRF 1-29) | About 30 minutes | Short, natural style pattern |
CJC 1295 without DAC may be used online to refer to modified GRF 1-29.
The main published human studies used the peptide with DAC
What Do the Human Clinical Trials on CJC-1295 Actually Show?
The human research on CJC-1295 shows one thing pretty clearly: The peptide can raise growth hormone and IGF-1 in people. That is the strongest and most consistent finding. In the main human CJC-1295 hormone study, growth hormone rose 2- to 10-fold and IGF-1 rose 1.5- to 3-fold after treatment. In the human CJC-1295 growth hormone pulse study, average growth hormone rose 46% and IGF-1 rose 44% one week after one injection.
But that appears to be where the strong proof mostly stops.
These studies were not designed to prove that this GHRH analog helps people lose fat, build muscle, sleep better, recover faster, improve skin, or slow aging. Most of the research measured hormone changes, not real-world outcomes. That matters because raising a hormone does not automatically mean people will see visible or meaningful health benefits.
Another important point is that the studies were small and don't last long. The main human CJC hormone study lasted 28 to 49 days. The growth hormone pulse study and the CJC-1295 blood protein marker study looked at changes about one week after treatment.
| Study | Study design | Results | Problems |
| Prolonged Stimulation of Growth Hormone and Insulin-Like Growth Factor I Secretion by CJC-1295 in Healthy Adults (2006) | Two randomized, placebo-controlled, double-blind trials in 21–61-year-old healthy adults; one tested single doses, one tested repeat weekly/biweekly dosing | GH rose 2- to 10-fold above baseline in a dose-dependent way; IGF-1 rose 1.5- to 3-fold and stayed elevated for 9–11 days after a single dose. The estimated half-life was about 6 to 8 days. | Involved healthy men/women with normal IGF-1 levels. It did not measure muscle mass, strength, sleep, quality of life, or other real-world outcomes. Study 1 lasted 28 days and study 2 lasted 49 days so not long enough to know what happens after several months. Supported by ConjuChem |
| Pulsatile Secretion of Growth Hormone Persists During Continuous Stimulation by CJC-1295 (2006) | Human intervention study measuring overnight growth hormone pulses before and 1 week after in 20 healthy men ages 20–40. (only 12 men in final analysis) | Average GH increased 46% and IGF-1 increased 44%.CJC did not create bigger GH spikes. Rather, it raised the low points between GH pulses, so overall exposure increased while normal GH pulses were preserved. | Only 12 men appear to be used in final analysis (not sure what happened to the 8 other men). Results are only after 1-week follow-up, so the study does not tell what happens after several months. Did not measure fat loss, sleep, muscle, or strength. No placebo group. No women. Supported by ConjuChem |
| Activation of the GH/IGF-1 Axis by CJC-1295 Results in Serum Protein Profile Changes in Normal Adult Subjects (2009) | Biomarker trial using blood samples taken before and 1 week after CJC injection. 11 healthy young adult men. | Researchers found significant changes in 5 blood protein spots after CJC. This supports activation of the GH/IGF-1 pathway, but it does not prove fat loss, muscle gain, sleep, recovery, or anti-aging benefits. | Small study. Only a 1-week follow-up, so we can't tell what happens after several months. Results come from blood samples of the 11 men used in the Ionescu 2006 study. Does not show CJC burns fat, helps sleep or builds muscle. No women included. Supported by ConjuChem and WADA |
Big Picture Takeaway
CJC-1295 has human evidence showing it raises GH and IGF-1. It does not have strong human evidence supporting the benefits most people are seeking, such as fat loss, muscle gain, better sleep, faster recovery, or anti-aging effects.
What Happened in the Halted CJC-1295 Phase 2 HIV Trial?
In 2006, ConjuChem funded a 12-week multicenter, randomized, placebo-controlled, double-blind Phase 2 trial of CJC-1295 in people with HIV-associated visceral obesity involving 192 people. The study was halted near the end of the treatment period after one participant died. According to an FDA Briefing Document, the participant developed chest pain about two hours after receiving the 11th weekly dose and later died from a heart attack. This does not prove the peptide caused the death, but it remains an important part of the peptide’s safety history.
Does CJC 1295 Help With Fat Loss?
There is no strong published human evidence showing the peptide causes meaningful fat loss in otherwise healthy adults.
While some may say CJC 1295 “supports fat metabolism” or “helps burn stubborn belly fat,” those claims are based mostly on the biology of growth hormone, not on direct CJC fat-loss trials in healthy people.
Growth hormone can influence fat metabolism. But raising a hormone marker does not automatically mean a person will lose visible body fat.
Does CJC 1295 Build Muscle?
CJC 1295 has not been proven to build muscle in healthy adults. While the logic sounds plausible, no human study to date has investigated whether the peptide helps people pack on muscle or improve muscle strength. This is a shortcoming of the human studies summarized above. They look at whether the peptide raises growth hormone but do not go the extra step to see if those elevations in GH result in the meaningful effects in real-life benefits people are looking for.
What I Would Ask
When presented with impressive before-and-after photos, ask whether those results came from CJC peptide alone or from diet, exercise, testosterone, GLP-1 meds, or calorie restriction. Request to see clinical trials on the peptide to prove the claims being made.
Does CJC 1295 Improve Sleep?
CJC 1295 has not been directly proven to improve sleep in human clinical trials.
The sleep claim comes from the relationship between growth hormone, GHRH, and deep sleep. Growth hormone is naturally linked to sleep, especially slow-wave sleep. Slow-wave sleep is the deeper, more restorative part of sleep.
But the human studies did not use sleep studies, sleep trackers, insomnia scores, or overnight sleep tests that measure brain waves, breathing, oxygen, and movement.
So, sleep improvement is possible in some people, but it is not proven by good CJC 1295 trials.
Does CJC 1295 Help Recovery From Injuries?
There is no solid human clinical trial evidence that CJC speeds injury healing.
This claim usually comes from the fact that growth hormone and IGF-1 are involved in collagen production and tissue repair. Collagen is a structural protein found in tendons, ligaments, skin, and other connective tissues.
That does not mean the CJC peptide heals injuries in people. To prove that, researchers would need controlled trials in people with specific injuries, such as tendon injuries, muscle tears, or post-surgical recovery.
Those trials are not the same as measuring hormone levels in healthy adults.
Is CJC 1295 Anti-Aging?
CJC 1295 is not proven to slow aging.
Growth hormone and IGF-1 decline with age. That is true. But reversing an age-related hormone change does not automatically mean you are slowing aging or improving healthspan.
The anti-aging claim needs hard evidence, such as:
- Better physical function
- Lower disease risk
- Fewer fractures
- Better mobility
- Better quality of life
- Longer life
CJC 1295 does not have that kind of evidence.
There may also be tradeoffs. IGF-1 helps growth and repair, but it is also involved in cell growth. That is one reason people with a history of cancer, active cancer, or high cancer risk should be especially careful with anything that raises the growth hormone/IGF-1 axis.
Is CJC 1295 FDA-Approved?
No. CJC 1295 is not FDA-approved.
The FDA has also raised concerns about compounded drugs containing the CJC peptide. The agency says compounded drugs containing CJC 1295 carry a risk of immune reaction, in which the immune system may respond to the peptide or impurities in the product. That matters because immune reactions can range from mild to serious.
The FDA says it has identified serious adverse events associated with CJC, including increased heart rate and systemic vasodilatory reaction, which can cause flushing, warmth, dizziness, and low blood pressure.
Is CJC-1295 Safe? Side Effects and Risks
Because it hasn't received FDA approval, there's no large-scale, long-term safety database as there is for an approved medication. What we do have comes from the trials above, from FDA safety communications about compounded peptides, and from the broader research on elevated growth hormone levels.
Commonly Reported Side Effects of This Peptide:
- Injection site reactions: redness, itching, or small lumps where the shot was given
- Flushing and warmth: temporary widening of blood vessels can cause a hot, flushed feeling
- Water retention: mild swelling, sometimes with tingling or numbness in the hands (carpal tunnel-like symptoms) (GH-related concern)
- Headache and mild GI symptoms: nausea has been reported in some groups
More Serious Risks to Know About
- Immunogenicity: a medical term for your immune system mistakenly treating the peptide as a threat and mounting a reaction against it, which the FDA flags as a risk and in rare cases can be severe
- Cardiovascular effects: increased heart rate and blood pressure changes have been flagged by the FDA for this compound class
- Cancer-related caution: because IGF-1 promotes cell growth, growth hormone secretagogues are generally considered inappropriate for anyone with a cancer diagnosis or a history of hormone-sensitive cancers
- Insulin resistance: elevated GH can make it harder for your body to manage blood sugar, which matters for anyone with prediabetes or a family history of diabetes
My Thoughts
Most human research on CJC peptide involved small studies that did not last long. That is not enough to determine long-term safety. Also, product claims such as “certified,” “lab-tested,” or “research grade” do not necessarily mean the product is equivalent to what was used in clinical trials. A peptide sold online may not meet the same purity, sterility, or manufacturing standards as a pharmaceutical product intended for injection.
Is CJC-1295 Legal?
CJC-1295 sits in a gray area for most people. It is not a dietary supplement, and it is not the same as an FDA-approved medication you pick up from a local pharmacy. In the United States, it is not FDA-approved for fat loss, muscle gain, sleep, recovery, anti-aging, or any medical condition. That means the FDA has not reviewed and approved it as safe and effective for those uses.
This does not mean every person who possesses CJC-1295 is automatically committing a crime. But it does mean people should be careful about how it is marketed and sold. If a company sells this peptide as a treatment for fat loss, muscle growth, anti-aging, injury recovery, or sleep without FDA approval, that can raise regulatory concerns because those are drug-like claims.
Athletes have another issue: CJC-1295 is prohibited in sport. The World Anti-Doping Agency (WADA) lists growth hormone-releasing factors as prohibited, including CJC-1295. This means tested athletes should not use it unless their governing body and anti-doping rules clearly allow it, which they generally do not.
Be careful when traveling with peptides, especially at airports, as they may get the attention of TSA.
Who Should Be Especially Careful With CJC-1295
Because the peptide has no FDA-approved use, there are no official criteria for who should use it. People should be especially cautious if they have cancer, a history of hormone-sensitive cancer, uncontrolled diabetes, significant heart disease, abnormal heart rhythms, pregnancy, breastfeeding, or if they compete in drug-tested sports.
Remember
None of this is a substitute for an actual medical evaluation. A licensed provider can order the bloodwork (IGF-1 levels, metabolic panel) needed to know whether any of this is even relevant to your situation.
What Questions Should You Ask Before Using CJC-1295?
Ask these questions before using any CJC-1295 product:
- Is this CJC-1295 with DAC or without DAC?
- Is it being legally prescribed?
- Is it coming from a reputable pharmacy, not a “research chemical” website?
- What lab tests will be conducted on me before and during use?
- What happens if IGF-1 rises too high?
- What side effects should make me stop taking it?
- Do I have any cancer, heart, blood sugar, or pituitary risk factors?
- Is the person selling it also giving me balanced safety information?
- Does the product have a certificate of analysis conducted by an independent lab to verify purity?
- Am I also changing diet, exercise, sleep, or other medications that could explain any results?
- What is the exit plan for when I stop taking the peptide?
If the only answer is “everyone feels better when they take it,” that is not enough.
Frequently Asked Questions
What is CJC-1295 used for?
CJC-1295 is studied for its ability to raise growth hormone and IGF-1 levels. It's not a dietary supplement, and it doesn't have an FDA-approved use; historically, it was in development for growth hormone deficiency and abnormal body fat changes linked to HIV before that program was discontinued.
What is CJC-1295 with DAC?
This is the long-acting version studied in humans. DAC helps the peptide bind to albumin in the blood, which extends how long it remains active. Human data suggest a half-life of about 5.8 to 8.1 days.
What is CJC-1295 without DAC?
If it does not contain DAC, it usually refers to modified GRF 1-29, a shorter-acting GHRH analog. It is not the same as the long-acting DAC version used in the main published human studies.
Does CJC-1295 increase IGF-1?
Yes. In one study, IGF-1 rose 1.5- to 3-fold for 9 to 11 days after one injection. In another trial, IGF-1 rose about 45% one week after injection.
Does CJC-1295 actually work?
It works in the narrow sense that it's been shown to raise GH and IGF-1 in healthy adults. Whether that translates into the muscle gain, fat loss, or anti-aging results often advertised hasn't been directly studied in humans.
Does CJC 1295 build muscle?
There is no strong human clinical trial evidence proving the CJC peptide builds muscle in healthy adults. The claim is based mostly on growth hormone and IGF-1 biology.
How long does it take to see results from CJC-1295?
There's no clinical trial data answering this question directly, since the human studies measured hormone levels in a lab setting rather than visible physical changes. Claims about specific timelines circulating online are not backed by published trials.
Is CJC-1295 safe and what are the side effects?
Short-term studies reported no serious adverse reactions, but those studies were small and did not last long. Reported effects include injection site irritation, flushing, water retention, headache, and mild nausea. The FDA has also flagged immunogenicity and cardiovascular risks for compounded versions.
Is CJC-1295 the same as HGH?
No. Human growth hormone (HGH) is the hormone itself. CJC-1295 doesn't contain growth hormone. It's a synthetic peptide that stimulates your pituitary gland to produce more of its own growth hormone.
Can athletes use CJC-1295?
Competitive athletes should be cautious. Growth hormone-releasing compounds are generally prohibited in sport, and CJC-1295 is on the WADA prohibited list.
Does it help women going through menopause?
The human trials to date enrolled both men and women among healthy adults, but no study has specifically evaluated CJC-1295 in women navigating perimenopause or menopause. Claims about menopause-specific benefits are theoretical rather than clinically proven.
What Should People Believe?
CJC-1295 has been shown to raise growth hormone and IGF-1 in several small human clinical trials. But the marketing is ahead of the evidence.
If someone says CJC-1295 “supports growth hormone,” that is reasonable. If they say it is proven to melt belly fat, build muscle, slow aging, heal injuries, or transform your body, that is a different story. The research is intriguing, but it does not have strong human proof for the benefits most people are looking for.
This article is for informational purposes only and is not medical advice. CJC-1295 is not FDA-approved for any use. Consult a licensed healthcare provider before considering any peptide therapy.
Leave a Reply